HEALWELL AI INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.79 USD | +2.43% |
|
+4.07% | +225.99% |
| Sales 2024 * | 41.21M 30.25M | Sales 2025 * | 72.44M 53.18M | Capitalization | 328M 241M |
|---|---|---|---|---|---|
| Net income 2024 * | -22M -16.15M | Net income 2025 * | -17M -12.48M | EV / Sales 2024 * | 7.97 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.53 x |
| P/E ratio 2024 * |
-12.8
x | P/E ratio 2025 * |
-24.9
x | Employees | 102 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.66% |
More Fundamentals
* Assessed data
More news
Latest transcript on Healwell AI Inc.
More press releases
More news
| 1 day | +2.43% | ||
| 1 week | +4.07% | ||
| Current month | -0.56% | ||
| 1 month | +27.87% | ||
| 3 months | +153.08% | ||
| 6 months | +225.45% | ||
| Current year | +225.99% |
1 week
1.69
1.81
1 month
1.392.26
Current year
0.482.26
1 year
0.232.26
3 years
0.232.26
5 years
0.232.26
10 years
0.232.26
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | - | 20-08-31 | |
Madeline Walker
PRN | Corporate Officer/Principal | - | 12-12-31 |
Blake Corbet
PRN | Corporate Officer/Principal | - | 23-10-01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hamed Shahbazi
CHM | Chairman | 49 | 23-09-30 |
Bashar Al-Rehany
BRD | Director/Board Member | 66 | 20-12-28 |
J. Ward
BRD | Director/Board Member | 60 | 20-12-28 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-03 | 1.79 | +2.43% | 1,346 |
| 24-07-02 | 1.748 | -3.45% | 78,458 |
| 24-07-01 | 1.81 | +0.56% | 172 |
| 24-06-28 | 1.8 | +7.14% | 24,303 |
| 24-06-27 | 1.68 | -2.33% | 21,460 |
Delayed Quote OTC Markets, July 03, 2024 at 12:58 pm EDT
More quotes
HEALWELL AI Inc. is a Canada-based healthcare technology company focused on artificial intelligence (AI) and data science for preventative care. The Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases. The Company's segments include Medical Clinics, Health Technology and Electronic Health Records. It provides government-insured primary and specialty healthcare through medical clinics, technology-enabled rare disease screening, clinical research, pulmonary function testing lab services, AI-driven healthcare information analytics and insights and subscription-based electronic health record information software. Its products include Khure Health, Pentavere, PolyClinic and WELL AI Decision Support. The Company provides clinical information sources and clinical insights. Its clinical information sources include clinical research and trials, lab and diagnostic info, and semi-structured data.
Calendar
2024-08-11
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.37
CAD
Average target price
3.95
CAD
Spread / Average Target
+66.67%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -36.66% | 13.17B | |
| +4.98% | 11.81B | |
| -4.50% | 11.28B | |
| +9.13% | 10.67B | |
| +12.65% | 7.14B | |
| -10.61% | 7.13B | |
| +9.12% | 6.5B | |
| +12.27% | 4.25B | |
| +32.50% | 4.09B |
- Stock Market
- Equities
- AIDX Stock
- HWAIF Stock
